Lung Ablation Outcomes for Inoperable Stage IA Non–Small Cell Lung Cancer

20250 citationsJournal Articlehybrid Open Access

Authors

Sameer Rehman · HealthPartners

Shreyas Naidu · University of Florida

Raja Shehayar Mehdi · University Medical Center of Southern Nevada

Syed Akbarullah · Pulmonary Associates

Dustin L Boyer · Clinical Research Center of Nevada

Nauman Jahangir · nView Medical (United States)

Michael Schunk

Abstract

Percutaneous cryoablation provides effective local control with a favorable safety profile in patients with medically inoperable Stage IA NSCLC particularly with tumor smaller than 2.0 cm. These results support further exploration of cryoablation as a primary treatment modality for this patient population.

Topics & Keywords

Hepatocellular Carcinoma Treatment and Prognosis Lung Cancer Diagnosis and Treatment Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Vascular and Interventional Radiology

Volume 37, Issue 3, pp. 107974-107974

DOI: 10.1016/j.jvir.2025.107974

Field-Weighted Citation Impact: 0.00